Cargando…

The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years

Detalles Bibliográficos
Autores principales: Hussein, Nawfal R, Naqid, Ibrahim A, Salih, Haval M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202348/
https://www.ncbi.nlm.nih.gov/pubmed/32395216
http://dx.doi.org/10.4084/MJHID.2020.027
_version_ 1783529695507120128
author Hussein, Nawfal R
Naqid, Ibrahim A
Salih, Haval M
author_facet Hussein, Nawfal R
Naqid, Ibrahim A
Salih, Haval M
author_sort Hussein, Nawfal R
collection PubMed
description
format Online
Article
Text
id pubmed-7202348
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-72023482020-05-11 The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years Hussein, Nawfal R Naqid, Ibrahim A Salih, Haval M Mediterr J Hematol Infect Dis Letter to the Editor Università Cattolica del Sacro Cuore 2020-05-01 /pmc/articles/PMC7202348/ /pubmed/32395216 http://dx.doi.org/10.4084/MJHID.2020.027 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Hussein, Nawfal R
Naqid, Ibrahim A
Salih, Haval M
The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title_full The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title_fullStr The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title_full_unstemmed The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title_short The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
title_sort efficacy and safety of intralesional sodium stibogluconate for the treatment of cutaneous leishmaniasis in children under the age of two years
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202348/
https://www.ncbi.nlm.nih.gov/pubmed/32395216
http://dx.doi.org/10.4084/MJHID.2020.027
work_keys_str_mv AT husseinnawfalr theefficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears
AT naqidibrahima theefficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears
AT salihhavalm theefficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears
AT husseinnawfalr efficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears
AT naqidibrahima efficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears
AT salihhavalm efficacyandsafetyofintralesionalsodiumstibogluconateforthetreatmentofcutaneousleishmaniasisinchildrenundertheageoftwoyears